EE04154B1 - Omeprasooli valmistamise meetod - Google Patents

Omeprasooli valmistamise meetod

Info

Publication number
EE04154B1
EE04154B1 EEP199900391A EEP9900391A EE04154B1 EE 04154 B1 EE04154 B1 EE 04154B1 EE P199900391 A EEP199900391 A EE P199900391A EE P9900391 A EEP9900391 A EE P9900391A EE 04154 B1 EE04154 B1 EE 04154B1
Authority
EE
Estonia
Prior art keywords
omeprazole
preparation
Prior art date
Application number
EEP199900391A
Other languages
English (en)
Estonian (et)
Inventor
Kristina Cotton Hanna
Magnus Larsson Erik
Mattson Anders
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9900391A publication Critical patent/EE9900391A/xx
Publication of EE04154B1 publication Critical patent/EE04154B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
EEP199900391A 1997-11-14 1998-11-03 Omeprasooli valmistamise meetod EE04154B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704183A SE9704183D0 (sv) 1997-11-14 1997-11-14 New process
PCT/SE1998/001984 WO1999025711A1 (en) 1997-11-14 1998-11-03 New process

Publications (2)

Publication Number Publication Date
EE9900391A EE9900391A (et) 2000-04-17
EE04154B1 true EE04154B1 (et) 2003-10-15

Family

ID=20408989

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900391A EE04154B1 (et) 1997-11-14 1998-11-03 Omeprasooli valmistamise meetod

Country Status (35)

Country Link
US (1) US6303788B1 (xx)
EP (1) EP0964859A1 (xx)
JP (1) JP2001508466A (xx)
KR (1) KR20000070069A (xx)
CN (1) CN1145624C (xx)
AR (1) AR013740A1 (xx)
AU (1) AU750743B2 (xx)
BR (1) BR9806871A (xx)
CA (1) CA2276753A1 (xx)
DE (1) DE964859T1 (xx)
DZ (1) DZ2641A1 (xx)
EE (1) EE04154B1 (xx)
ES (1) ES2138950T1 (xx)
GR (1) GR990300046T1 (xx)
HR (1) HRP990218A2 (xx)
HU (1) HUP0003737A3 (xx)
ID (1) ID21999A (xx)
IL (1) IL130647A0 (xx)
IN (1) IN190801B (xx)
IS (1) IS5106A (xx)
MA (1) MA26564A1 (xx)
MY (1) MY118199A (xx)
NO (1) NO318197B1 (xx)
NZ (1) NZ336447A (xx)
PL (1) PL334701A1 (xx)
RU (1) RU2211218C2 (xx)
SE (1) SE9704183D0 (xx)
SK (1) SK87299A3 (xx)
TN (1) TNSN98202A1 (xx)
TR (1) TR199901643T1 (xx)
TW (1) TW588046B (xx)
UA (1) UA68342C2 (xx)
WO (1) WO1999025711A1 (xx)
YU (1) YU31199A (xx)
ZA (1) ZA989999B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
IL142703A (en) 1998-11-10 2006-04-10 Astrazeneca Ab Crystalline form of omeprazole
UA72748C2 (en) 1998-11-10 2005-04-15 Astrazeneca Ab A novel crystalline form of omeprazole
CN1876647A (zh) 2001-02-02 2006-12-13 特瓦制药工业有限公司 苯并咪唑化合物产品
SE0203092D0 (en) * 2002-10-18 2002-10-18 Astrazeneca Ab Method for the synthesis of a benzimidazole compound
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2006040635A1 (en) * 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited Processes for the preparation of substituted sulfoxides
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
CN1810803B (zh) * 2006-02-17 2010-11-17 中国科学院上海有机化学研究所 高对映体选择性制备(s)-奥美拉唑的方法
CN101538264A (zh) * 2008-03-19 2009-09-23 中国科学院成都有机化学有限公司 手性亚砜类化合物的制备新方法
CN102603621B (zh) * 2012-02-07 2013-09-04 成都苑东药业有限公司 一种新型手性亚砜化合物和以该化合物制备埃索美拉唑钠的方法
CN106083819A (zh) * 2016-06-08 2016-11-09 扬子江药业集团有限公司 一种奥美拉唑的制备方法
ES2948511A1 (es) * 2021-09-08 2023-09-13 Fundacion Para La Investigacion Biomedica Del Hospital Univ De La Princesa Derivados de n-sulfonilureas y su uso terapeutico

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE9002043D0 (sv) 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
NZ244301A (en) 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider

Also Published As

Publication number Publication date
BR9806871A (pt) 2000-04-18
MY118199A (en) 2004-09-30
NO993298D0 (no) 1999-07-02
IN190801B (xx) 2003-08-23
AU1058299A (en) 1999-06-07
SK87299A3 (en) 2000-02-14
YU31199A (sh) 2002-06-19
TR199901643T1 (xx) 2000-01-21
EE9900391A (et) 2000-04-17
NZ336447A (en) 2001-02-23
DZ2641A1 (fr) 2003-03-15
KR20000070069A (ko) 2000-11-25
GR990300046T1 (en) 2000-07-31
SE9704183D0 (sv) 1997-11-14
NO318197B1 (no) 2005-02-14
ES2138950T1 (es) 2000-02-01
HUP0003737A3 (en) 2002-01-28
AR013740A1 (es) 2001-01-10
DE964859T1 (de) 2000-05-04
US6303788B1 (en) 2001-10-16
MA26564A1 (fr) 2004-12-20
ZA989999B (en) 1999-06-17
NO993298L (no) 1999-07-02
WO1999025711A1 (en) 1999-05-27
UA68342C2 (en) 2004-08-16
AU750743B2 (en) 2002-07-25
JP2001508466A (ja) 2001-06-26
RU2211218C2 (ru) 2003-08-27
PL334701A1 (en) 2000-03-13
HUP0003737A2 (hu) 2001-10-28
ID21999A (id) 1999-08-19
CN1145624C (zh) 2004-04-14
CA2276753A1 (en) 1999-05-27
CN1243512A (zh) 2000-02-02
IS5106A (is) 1999-07-02
TNSN98202A1 (fr) 2005-03-15
IL130647A0 (en) 2000-06-01
EP0964859A1 (en) 1999-12-22
TW588046B (en) 2004-05-21
HRP990218A2 (en) 2000-08-31

Similar Documents

Publication Publication Date Title
CY2012029I1 (el) Νεα μορφη της s-ομεπραζολης
IS5245A (is) Lyfjablanda úr ómeprasól
NO993068L (no) Ny forbindelsesform
NO994757L (no) Fremgangsmåte for oral administrasjon av proteiner
NO986202D0 (no) FremgangsmÕte for fremstilling av rekombinant adÚnovirus
PT1150966E (pt) Metodo de preparacao de 5-cianoftalido
ID26990A (id) Metode pembuatan dimetilnaftalena
EE04154B1 (et) Omeprasooli valmistamise meetod
FI980246A0 (fi) Menetelmä keittimen käyttämiseksi ja keitin
ID20733A (id) Metode pembuatan sikat
ID18300A (id) Metoda penemperan
HUP9903744A3 (en) Method of omeprazole preparation
ID19540A (id) Metode pembuatan turunan-turunan benzofenon
FI972592A (fi) Synkronointimenetelmä
ID23019A (id) Metode pembuatan turunan nitroguadinin
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
IS5077A (is) Öragna form tetrahýdrópýrídínafleiðu
FI974235A0 (fi) Ny bestaemningsmetod
UA25260A (uk) Спосіб отримаhhя 2-феhіл-3-карбетокси-5-гідроксибеhзофураhу
UA26025C2 (uk) Спосіб одержаhhя портлаhдцемеhтhого кліhкеру
FI103308B1 (fi) Synkronointimenetelmä
UA25135A (uk) Спосіб гастроєюhопластики
UA25653A (uk) Спосіб проведеhhя скальптерапії
UA25353A (uk) Спосіб холецистостомії
UA25398A (uk) Спосіб комбіhоваhої холецистолітотомії

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

MM4A Lapsed by not paying the annual fees

Effective date: 20061103